NO20005022D0 - Inhibering av binding av Hox og homeodomeninneholdende proteiner og anvendelser derav - Google Patents

Inhibering av binding av Hox og homeodomeninneholdende proteiner og anvendelser derav

Info

Publication number
NO20005022D0
NO20005022D0 NO20005022A NO20005022A NO20005022D0 NO 20005022 D0 NO20005022 D0 NO 20005022D0 NO 20005022 A NO20005022 A NO 20005022A NO 20005022 A NO20005022 A NO 20005022A NO 20005022 D0 NO20005022 D0 NO 20005022D0
Authority
NO
Norway
Prior art keywords
homeodome
hox
inhibition
binding
containing proteins
Prior art date
Application number
NO20005022A
Other languages
English (en)
Other versions
NO20005022L (no
Inventor
Xu Cao
Xingming Shi
Zhijie Chang
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of NO20005022D0 publication Critical patent/NO20005022D0/no
Publication of NO20005022L publication Critical patent/NO20005022L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20005022A 1998-04-06 2000-10-05 Inhibering av binding av hox og homeodomen-inneholdende proteiner og anvendelser derav NO20005022L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8085998P 1998-04-06 1998-04-06
PCT/US1999/007455 WO1999051217A1 (en) 1998-04-06 1999-04-05 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof

Publications (2)

Publication Number Publication Date
NO20005022D0 true NO20005022D0 (no) 2000-10-05
NO20005022L NO20005022L (no) 2000-12-04

Family

ID=22160102

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005022A NO20005022L (no) 1998-04-06 2000-10-05 Inhibering av binding av hox og homeodomen-inneholdende proteiner og anvendelser derav

Country Status (10)

Country Link
US (2) US6284464B1 (no)
EP (1) EP1075255A4 (no)
JP (1) JP2002510620A (no)
CN (1) CN1154507C (no)
AU (1) AU757105B2 (no)
CA (1) CA2324976A1 (no)
IL (1) IL138832A0 (no)
NO (1) NO20005022L (no)
NZ (1) NZ507251A (no)
WO (1) WO1999051217A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003091409A2 (en) * 2002-04-24 2003-11-06 Osteoscreen, Inc. Identification of compounds which stimulate bone formation using a cell-based screening assay targeting bmp signaling
US20060008794A1 (en) * 2004-07-06 2006-01-12 Rhodes Craig S HOX code functions as a growth synchronizing moving reference frame

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction

Also Published As

Publication number Publication date
US6284464B1 (en) 2001-09-04
CA2324976A1 (en) 1999-10-14
IL138832A0 (en) 2001-10-31
US20020082235A1 (en) 2002-06-27
JP2002510620A (ja) 2002-04-09
CN1310618A (zh) 2001-08-29
AU757105B2 (en) 2003-01-30
NO20005022L (no) 2000-12-04
NZ507251A (en) 2005-04-29
CN1154507C (zh) 2004-06-23
EP1075255A1 (en) 2001-02-14
WO1999051217A1 (en) 1999-10-14
EP1075255A4 (en) 2005-01-26
AU3470899A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
FI973596A0 (fi) Identifikation av talaktiviteten av en kaella
NO20032753D0 (no) Forbindelse og anvendelse derav
NO20013288D0 (no) Bestemmelse av vannmetning og sandfraksjon
NO994441D0 (no) Ekstraksjon og anvendelse av VNTR-alleler
PT946323E (pt) Pos de niobio e condensadores eletroliticos de niobio
DK0946547T3 (da) Hidtil ukendt forbindelsesform
DK1014993T3 (da) Hidtil ukendt anvendelse af budesonid og formoterol
NO20022334L (no) Ny sammensetning og anvendelse
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
NO20006488D0 (no) Sammensetning og anvendelse
DE69630244D1 (de) Snowboardstiefel und bindung
DK1112003T3 (da) Ny sammensætning og anvendelse
DK1047450T3 (da) Kombinationer af ACE-inhibitorer og MMP-inhibitorer
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO20021832D0 (no) Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO975178D0 (no) Belegningsblanding og anvendelse av denne
NO20005022D0 (no) Inhibering av binding av Hox og homeodomeninneholdende proteiner og anvendelser derav
HUP0102850A2 (hu) Eljárások és kompozíciók fehérje funkcióinak meghatározására és módosítóinak azonosítására
PT1140994E (pt) Proteinas da superficie externa, suas genes e sua utilizacao
NO980237D0 (no) Termobindende fôr og fremstilling derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application